18 May 2013
Keywords: new, ph, ii, sa, trial, intercell/merck, co
Article | 01 September 2008
Austrian vaccines specialist Intercell says that its partner, US drug major Merck & Co, has initiated a Phase II clinical trial ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 September 2008
17 May 2013
© 2013 thepharmaletter.com